9001cc金沙首页(以诚为本)Official website /tag/michael-garvey/ 鍏ㄦ柟浣嶇殑鍒嗗瓙妫€娴嬨€佸垱鏂板尰鑽€佸尰鐤楁湇鍔?鍋ュ悍涔愬湡锛岀浣戜紬鐢烖/description> Tue, 26 Oct 2021 01:50:11 +0000 zh-CN hourly 1 https://wordpress.org/?v=6.1.7 杩堝厠灏斅烽珮浼燂細涓浗鍖昏嵂鐢熺墿浜т笟姝ｈ繘鍏ラ粍閲戝彂灞曢樁娈袋/title> <link>/2021/10/%e8%bf%88%e5%85%8b%e5%b0%94%c2%b7%e9%ab%98%e4%bc%9fmichael-garvey%ef%bc%9a%e4%b8%ad%e5%9b%bd%e5%8c%bb%e8%8d%af%e7%94%9f%e7%89%a9%e4%ba%a7%e4%b8%9a%e6%ad%a3%e8%bf%9b%e5%85%a5%e9%bb%84%e9%87%91/</link> <dc:creator><![CDATA[CLB]]></dc:creator> <pubDate>Tue, 19 Oct 2021 01:48:28 +0000</pubDate> <category><![CDATA[涓撶]]></category> <category><![CDATA[鏂伴椈]]></category> <category><![CDATA[棣栭〉鏂囩珷]]></category> <category><![CDATA[CDMO]]></category> <category><![CDATA[Michael Garvey]]></category> <guid isPermaLink="false">/?p=8122</guid> <description><![CDATA[<p>涓浗鍖昏嵂鐢熺墿浜т笟姝ｄ粠鏇村鐨勪复搴婇樁娈佃繃娓″埌鏇村鐨勫晢涓氶樁娈碉紝搴斿鍏虫敞涓浗甯傚満</p> <p>The post <a rel="nofollow" href="/2021/10/%e8%bf%88%e5%85%8b%e5%b0%94%c2%b7%e9%ab%98%e4%bc%9fmichael-garvey%ef%bc%9a%e4%b8%ad%e5%9b%bd%e5%8c%bb%e8%8d%af%e7%94%9f%e7%89%a9%e4%ba%a7%e4%b8%9a%e6%ad%a3%e8%bf%9b%e5%85%a5%e9%bb%84%e9%87%91/">杩堝厠灏斅烽珮浼燂細涓浗鍖昏嵂鐢熺墿浜т笟姝ｈ繘鍏ラ粍閲戝彂灞曢樁娈袋/a> appeared first on <a rel="nofollow" href="">涔愬湡鐢熷懡绉戞妧</a>.</p> ]]></description> <content:encoded><![CDATA[<p>娣卞湷甯備箰鍦熺敓鍛界鎶€鎶曡祫鏈夐檺鍏徃鎬昏杩堝厠灏斅烽珮浼 (Michael Garvey) 鏃ュ墠鍦ㄦ帴鍙楁柊鍗庣ぞ璁拌€呬笓璁挎椂琛ㄧず锛屼腑鍥藉尰鑽敓鐗╀骇涓氭浠庢洿澶氱殑涓村簥闃舵杩囨浮鍒版洿澶氱殑鍟嗕笟闃舵锛屽簲澶氬叧娉ㄤ腑鍥藉競鍦恒€侟/p> <p>鈥滆繃鍘诲崄骞达紝涓浗鍦ㄥ尰鐤椾骇涓氬凡缁忓疄鐜颁簡鎸囨暟澧為暱锛屾湭鏉ュ皢浼氭寔缁繘琛屾墿寮犮€備絾甯傚満鐨勫闀块渶瑕佷竴涓墠鎻愶紝閭ｅ氨鏄繀椤绘湁渚涘簲閾剧殑鍟嗕笟鍖栨墠鍙互瀹炵幇锛岃€屽浣曞疄鐜颁緵搴旈摼鐨勫晢涓氬寲锛屽讥琛ヤ緵闇€涔嬮棿鐨勫法澶у樊寮傦紝灏辨槸鎴戜滑鍔姏鐨勬柟鍚戙€傗€濋珮浼熻〃绀恒€侟/p> <p>楂樹紵瀵硅鑰呰锛岄€氳繃鍏徃瀵逛腑鍥藉競鍦虹殑鐮旂┒鏁版嵁锛屽崄鍒嗗潥瀹氬湴鐪嬪ソ涓浗甯傚満鍙戝睍娼滃姏銆傗€滀腑鍥芥湁鐩稿綋澶氱殑鍖昏嵂鐢熺墿浜т笟鍙互鏈嶅姟浜庡叏鐞冨競鍦猴紝寰堝ぇ绋嬪害涓婃槸涓€涓闀垮競鍦猴紝姝ｅ浜庝粠涓村簥闃舵鍚戝晢涓氶樁娈碉紝鍥藉唴鍟嗕笟鍚戝叏鐞冨晢涓氳繃娓＄殑鍏抽敭闃舵銆傗€滭/p> <p><img decoding="async" class="aligncenter size-full wp-image-8123" src="/wp-content/uploads/2021/10/1-1.png" alt="" width="1059" height="635" srcset="/wp-content/uploads/2021/10/1-1.png 1059w, /wp-content/uploads/2021/10/1-1-300x180.png 300w, /wp-content/uploads/2021/10/1-1-1030x618.png 1030w, /wp-content/uploads/2021/10/1-1-768x461.png 768w, /wp-content/uploads/2021/10/1-1-705x423.png 705w" sizes="(max-width: 1059px) 100vw, 1059px" /></p> <p>杩欏浣嶄簬娣卞湷鐨勭敓鐗╁尰鑽紑鍙戝埗閫犱紒涓氭垚绔嬩簬2016骞达紝浠ュ紩杩涘浗闄呭墠娌跨敓鐗╁尰鑽妧鏈拰浜у搧涓烘牳蹇冿紝鎵撻€犻泦妫€娴嬨€佸尰鑽€佸尰鐤椾负涓€浣撶殑鐢熷懡绉戞妧鐢熸€併€佷笘鐣岀骇鍖荤枟鍋ュ悍绉戞妧浼佷笟銆備粖骞?鏈堬紝楂樹紵琚换鍛戒负璇ュ叕鍙哥殑鎬荤粡鐞嗭紝姝ゅ墠鎷ユ湁瓒呰繃20骞寸殑鍥介檯鐢熺墿鎶€鏈拰CDMO缁忛獙锛屾浘鍦ㄧ編鍥姐€佷簹娲插拰娆ф床鐨勭敓鐗╁埗鑽紒涓氭媴浠荤鐞嗚亴鍔°€傛浘鍦ㄤ笁鏄熺敓鐗╁埗鑽叕鍙革紙Samsung Biologics)鎷呬换鍒涘鎵ц濮斿憳鍜屽壇鎬昏锛岃礋璐ｄ负璁捐銆侀獙璇併€佹妧鏈浆璁┿€佽繍钀ュ伐浣滄彁渚涙敮鎸侊紝骞舵垚鍔熷湴涓哄崟涓繍钀ョ偣鐨勬渶澶ц嵂鍝佺敓浜ц鏂斤紙浜ц兘涓?62000L锛夊紩鍏ヨ秴杩?4绉嶆柊鑽€侟/p> <p>鈥滃綋鎴戜笌鍒涘浜哄垬濡傞摱浜よ皥鏃讹紝鍙戠幇鎴戜滑鏈夊叡鍚岀殑鎰挎櫙鍜岀洰鏍囷紝灏辨槸涓哄叏涓栫晫鎵€鏈変汉鎻愪緵骞惰В鍐充复搴婁笂鏈婊¤冻鐨勫尰鐤楅渶姹傦紝璁╀汉浠兘鑳借幏寰楅潪甯镐究瀹滅殑鑽墿鍜岀浉鍏抽厤濂楁湇鍔★紝鐢氳嚦鍙互鎻愪緵涓€浜涘厤璐圭殑鑽墿銆傗€濋珮浼熻銆侟/p> <p><img decoding="async" class="aligncenter size-full wp-image-8125" src="/wp-content/uploads/2021/10/2-2.png" alt="" width="868" height="578" srcset="/wp-content/uploads/2021/10/2-2.png 868w, /wp-content/uploads/2021/10/2-2-300x200.png 300w, /wp-content/uploads/2021/10/2-2-768x511.png 768w, /wp-content/uploads/2021/10/2-2-705x469.png 705w" sizes="(max-width: 868px) 100vw, 868px" /></p> <p>鈥滄垜鐪嬪埌涓浗鏈?4浜夸汉鍙ｏ紝鎴戞効鎰忓府鍔╁拰鍙戝睍杩欎釜甯傚満锛屽苟鍦ㄥ叾涓彂灞曚笅涓€浠ｇ敓鐗╂妧鏈€傗€濋珮浼熻〃绀恒€侟/p> <p>褰撻棶鍙婂浣曠湅寰呭尰鑽骇涓氬湪绮ゆ腐婢冲ぇ婀惧尯鍙戝睍鏃讹紝楂樹紵琛ㄧず锛岀菠娓境澶ф咕鍖烘槸涓€涓闀块潪甯稿揩鐨勫競鍦恒€傗€滀絾鎴戣涓烘垜浠渶瑕佸湪澶ф咕鍖哄鎵句竴浜涚獊鐮寸偣锛岀洰鍓嶏紝鍖昏嵂鐢熺墿浼佷笟鎵€闈㈠鐨勭珵浜夌幆澧冨彉寰楄秺鏉ヨ秺鍔ㄦ€佸寲锛屼紒涓氳鍙戞尌鑷韩浼樺娍锛屽缓绔嬪崗浣滃瀷绔炰簤鎴樼暐锛屽叡鍚岃惀閫犺壇濂界殑鍗忎綔鐜銆傗€滭/p> <p>楂樹紵鐩镐俊锛屼腑鍥藉緢鏈夊彲鑳藉湪鏈潵浜斿勾閲屾垚涓哄尰鐤楄涓氭渶澶х殑鍥藉锛屼箰鍦熺敓鍛戒篃灏嗚法瓒婂浗澧冭繘鍏ョ編鍥藉競鍦轰箖鑷冲叏鐞冨競鍦猴紝鍔姏鎴愪负涓栫晫鏈€澶х殑CDMO浼佷笟銆侟/p> <hr /> <h3><strong><b>Interview: China to lead and become largest market in global medical industry in next 5 yrs, says CLB president</b></strong></h3> <p><strong><em><b><i>Abstract :聽</i></b></em></strong><em><i>China’s biomedical industry is transiting from the more clinical stage into a more commercial stage, and Cheerland is now at a critical phase in China and will attach more importance to the Chinese market, Michael Garvey, Managing Director and President of Cheerland Biotechnology (CLB) said.</i></em></p> <p>Michael Garvey, Managing Director of the Board, President of Cheerland Biotechnology (CLB) speaks during an interview in Shenzhen, south China’s Guangdong Province, Oct. 15, 2021.</p> <p>BEIJING, Oct. 19 (Xinhua) — China’s biomedical industry is transiting from the more clinical stage into a more commercial stage, and Cheerland is now at a critical phase in China and will attach more importance to the Chinese market, Michael Garvey, Managing Director of the Board, President of Cheerland Biotechnology (CLB), told Xinhua at an interview in Shenzhen.</p> <p>Garvey places high hopes on the Chinese market, as he said that China is expected to taking the lead and become the largest market in the world medical industry in the next five years, and Cheerland, a cutting-edge biotech developer based in Shenzhen of south China’s Guangdong province, would take the advantage of Chinese market and expand businesses into the United States or even Europe to developing into the most vigorous CDMO enterprises in the world.</p> <p>To facilitate Chinese medical industry’s supply chain to attain a faster growth, Cheerland is helping to commercialize China’s the supply chain and balance the difference between demand and supply, according to Garvey.</p> <p>Data from Cheerland’s marketing house shows the company’s optimistic view about potential Chinese market in biomedical industry. Garvey added that China has a superb biology economic value to the global market, and it is a very fast growing market.</p> <p>Garvey said he upholded a philosophy to fulfill unmet medical needs to all people across the world, and provide access to all people to affordable medicines and supporting facilities, or even some medicines will do for free.</p> <p>Mentioning China with a huge population of 1.4 billion, 聽he would try to help foster the Chinese market and develop the next generation biotech technology within China, Garvey told Xinhua.</p> <p>“China’s Guangdong-Hong Kong-Macau Greater Bay Area is a very growth market, but I think some of our barriers that we need to look in the Greater Bay Area is how can we take it from a competitive advantage across companies to a collaborative environment,” said Garvey.</p> <p>With 25 years of experiences in international biotech & CDMO, Michael Garvey held various executive, technical, and operational leadership positions in biopharmaceutical companies in the Unite States, Asia, and Europe, who also served as Global Head of Technical Operations, BeiGene; a founding Executive member and Vice President of Samsung Biologics Manufacturing, where he helped design, validate, technology transfer, operate, and successfully licensed an impressive over 14 novel medicines in the largest Drug Substance facility (362,000L of capacity) in a single location.</p> <p>Founded in 2016, the CLB aims to build a world-class biotech enterprise, offering a wide array of products and services, ranging from diagnoses, pharmaceuticals, and healthcare services.</p> <p>(Contributed by Mao Lili, Li Yan, edited by Jiang Feifan with <a href="https://en.imsilkroad.com/p/324369.html">Xinhua聽Silk Road</a>)</p> <p>The post <a rel="nofollow" href="/2021/10/%e8%bf%88%e5%85%8b%e5%b0%94%c2%b7%e9%ab%98%e4%bc%9fmichael-garvey%ef%bc%9a%e4%b8%ad%e5%9b%bd%e5%8c%bb%e8%8d%af%e7%94%9f%e7%89%a9%e4%ba%a7%e4%b8%9a%e6%ad%a3%e8%bf%9b%e5%85%a5%e9%bb%84%e9%87%91/">杩堝厠灏斅烽珮浼燂細涓浗鍖昏嵂鐢熺墿浜т笟姝ｈ繘鍏ラ粍閲戝彂灞曢樁娈袋/a> appeared first on <a rel="nofollow" href="">涔愬湡鐢熷懡绉戞妧</a>.</p> ]]></content:encoded> </item> </channel> </rss>